The impact of recurrent glomerulonephritis on graft survival in recipients of human histocompatibility leucocyte antigen-identical living related donor grafts

Transplantation

Volumn 68, Issue 5, 1999, Pages 623-627

  Andresdottir, M B ^a   Hoitsma, A J ^a   Assmann, K J M ^a   Koene, R A P ^a   Wetzels, J F M ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

HISTOCOMPATIBILITY ANTIGEN; LEUKOCYTE ANTIGEN;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GLOMERULONEPHRITIS; GRAFT FAILURE; GRAFT REJECTION; GRAFT SURVIVAL; HUMAN; KIDNEY GRAFT; LIVING DONOR; MALE; PRIORITY JOURNAL; PROGNOSIS; RECURRENT DISEASE; SURVIVAL RATE;

ADULT; FEMALE; GLOMERULONEPHRITIS; GRAFT SURVIVAL; HISTOCOMPATIBILITY TESTING; HLA ANTIGENS; HUMANS; KIDNEY TRANSPLANTATION; LIVING DONORS; MALE; MIDDLE AGED; RECURRENCE; TIME FACTORS; TREATMENT OUTCOME;

EID: 0033568634     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-199909150-00005     Document Type: Article

References (27)

1. Cecka J, Terasaki P. The UNOS Scientific Renal Transplant Registry. In: Clin Transplant, Terasaki, Cecka, eds. Los Angeles, UCLA Tissue Typing Laboratory, 1993: 1.
2. Michielsen P. Recurrence of the original disease. Does this influence renal graft failure? Kidney Int 1995; 48 (suppl 52): S-79.
3. Seigler HF, Gunnells JC, Robinson RR, et al. Renal transplantation between HLA identical donor-recipient pairs. J Clin Invest 1972; 51: 3200.
4. Descamps B, Hinglais N, Crosnier J Renal transplantation between 33 HLA-identical siblings. Transplant Proc 1973; 5: 231.
5. Seigler HF, Ward FE, McCoy RE, Weinerth JL, Gunnells JC, Stickel DL. Long-term results with forty-five living related renal allograft recipients genotypically identical for HLA. Surgery 1977; 81: 274.
6. Patel R, Myrberg S. Value of prospective tissue typing in kidney transplantation between HLA identical siblings. Br Med J 1970; 4: 709.
7. Cheigh JS, Chami J, Stenzel KH, et al. Renal transplantation between HLA identical siblings; comparison with transplants from HLA semi-identical related donors. N Engl J Med 1977; 296: 1030.
8. First MR, Munda R, Kant KS, Fidler JP, Alexander JW. Steroid withdrawal following HLA-identical related donor transplantation. Transplant Proc 1981; 13: 319.
9. Flechner SM, Kerman RH, Van Buren CT, Lorber MI, Barker CJ, Kahan BD. Does cyclosporine improve the results of HLA-identical renal transplantation. Transplant Proc 1987; 19: 1485.
10. Agarwal SK, Tiwari SC, Dash SC, Mehta SN, Saxena S, Mehra NK. Results of renal transplantation using living-related HLA-identical donors. Nephron 1994; 66: 248.
11. Etheredge EE, Shons AR, Schmidtke JR, Najarian JS. Mixed leukocyte culture reactivity and rejection in renal transplantation in HLA-identical siblings. Transplantation 1974; 17: 537.
12. Ascher NL, Simmons RL, Noreen H, et al. 100 HLA-identical sibling transplants. Ann Surg 1979; 189: 209.
13. Chan GLC, Canafax DM, Ascher NL, et al. HLA-identical sibling renal transplants: No rejections with a cyclosporine-azathioprine-prednisone protocol. Clin Transplant 1988; 2: 9.
14. Van Buren D, MacDonell R, Johnson HK, et al. Cyclosporine improves results in HLA-identical sibling renal transplants. Transplant Proc 1994; 26: 2514.
15. Burke GW, Allouch M, Cirocco R, et al. Rejection in HLA-identical living related donor kidney transplants: Lack of predictive immunologic parameters. Transplantation 1994; 57: 750.
16. Baltzan MA, Shoker AS, Baltzan RB, George D. HLA-identity-Long-term renal graft survival, acute vascular, chronic vascular, and acute interstitial rejection. Transplantation 1996; 61: 881.
17. Fuggle S. Immunohistology of the transplant kidney. In: Morris P, ed. Kidney transplantation, Philadelphia: WB Saunders, 1994: 287.
18. Glassock RJ, Feldman D, Reynolds ES, Dammin GJ, Merrill JP. Human renal isografts: a clinical and pathologic analysis. Medicine 1968; 47: 411.
19. Kotanko P, Pusey CD, Levy JB. Recurrent glomerulonephritis following renal transplantation. Transplantation 1997; 63: 1045.
20. Hariharan S, Peddi VR, Savin VJ, et al. Recurrent and de novo renal diseases after renal transplantation: A report from the renal allograft disease registry. Am J Kidney Dis 1998; 31: 928.
21. Hariharan S, Pelz C, George V, et al. Risk factors for graft loss due to recurrent and de novo diseases after renal transplantation: A report from the renal allograft disease registry (RADR). J Am Soc Nephrol 1998; 9: 667A (Abstract).
22. Couchoud C, Pouteil-Noble C, Colon S, Touraine J Recurrence of membranous nephropathy after renal transplantation. Transplantation 1995; 59: 1275.
23. Andresdottir MB, Assmann KJM, Hoitsma AJ, Koene RAP, Wetzels JFM. Recurrence of type I membranoproliferative glomerulonephritis after renal transplantation. Transplantation 1997; 63: 1.
24. Cameron JS, Senguttuvan P, Hartley B, et al. Focal segmental glomerulosclerosis in fifty-nine renal allografts from a single centre; analysis of risk factors for recurrence. Transplant Proc 1989; 21: 2117.
25. Odum J, Peh C, Clarkson A, et al. Recurrent mesangial IgA nephritis following renal transplantation. Nephrol Dial Transplant 1994; 9: 309.
26. Tomlanovich S, Vincenti F, Amend W, et al. Is cyclosporine effective in preventing recurrence of immune-mediated glomerular disease after renal transplantation? Transplant Proc 1988; 20: 285.
27. Schwarz A, Krause PH, Offermann G, Keller F. Recurrent and de novo renal disease after kidney transplantation with or without cyclosporine A. Am J Kidney Dis 1991; 17: 524.